MINSK, 1 February (BelTA) – Belarus aims to export $200 million worth of pharmaceutical products in 2018, Belarus' Deputy Prime Minister Vasily Zharko said at a board meeting of the Healthcare Ministry on 1 February, BelTA has learned.
“The goal is to increase the export of Belarusian medications, keeping their share on the domestic market intact,” Vasily Zharko said.
“This year we will seek to reach $200 million in export. We have every opportunity to do this,” the deputy prime minister said. At least half of the output will be bound for the export in the future.
Addressing these tasks in the interests of the country will require teamwork, he said.
According to Vasily Zharko, there is a need to deal with the issue of intermediaries, to ensure strict control over the import of drugs and prices. Corresponding instructions have been given by the head of state, and they need to be executed in the first half of the year.
The move to set up the Belpharmprom holding company is designed to ensure the further qualitative development of the industry. “The key to competitiveness is to have a high share of innovative products in the total output. We need to actively develop the scientific potential and provide the industry with highly-skilled professionals able to deal with the challenges and design our own unique preparations,” the vice premier noted.
